Contract notice

Information

Published

Expire date: 13/07/2023

External Reference: 2023-599933

FTS Reference: 2023-012809

Contract notice

Contract notice

Section I: Contracting authority

I.1)

Name and addresses

Peninsula Purchasing & Supply Alliance
1234
Royal Devon University Healthcare NHS Foundation Trust
Exeter
South west region
UK
Contact person: Fiona Malloch
Telephone: +44 7867142061
NUTS code:  UKK -  SOUTH WEST (ENGLAND)
Internet address(es):
Address of the buyer profile: https://www.ppsa.nhs.uk/

I.2)

Joint procurement

The contract is awarded by a central purchasing body
I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:  
https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=67323&B=NHSSW
Additional information can be obtained from
the abovementioned address:  
Tenders or requests to participate must be submitted
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)

Type of the contracting authority

Regional or local authority
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Aseptically Manipulated or Terminally Sterile Medicinal Products
Reference number:  T22/0446
II.1.2)

Main CPV code

33600000  -  Pharmaceutical products
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags and pre-filled syringes.
This procurement is being managed by the Peninsula Purchasing and Supply Alliance (hereafter referred to as the PPSA) on behalf of the Royal Devon University Healthcare NHS Foundation Trust (hereafter referred to as the Organisation) acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.
II.1.5)

Estimated total value

Value excluding VAT: 80500000.00  GBP
II.1.6)

Information about lots

This contract is divided into lots: yes
Tenders may be submitted for  all lots
II.2)

Description

II.2.1)

Title

Aseptically prepared products
Lot No:  1
II.2.2)

Additional CPV code(s)

33690000  -  Various medicinal products
33692100  -  Infusion solutions
33692500  -  Injectable solutions
33692510  -  Intravenous fluids
33693100  -  Toxins
II.2.3)

Place of performance

NUTS code:  UKK -  SOUTH WEST (ENGLAND)
NUTS code:  UK -  UNITED KINGDOM
Main site or place of performance:  
Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire
II.2.4)

Description of the procurement

Supply of Cyclophosphamide, Doxorubicin & Pembrolizumab compounded ready-to-use batch and patient-specific products.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 46000000.00  GBP
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 48
This contract is subject to renewal: no
II.2.10)

Information about variants

Variants will be accepted: no
II.2.11)

Information about options

Options: yes
Description of options:
Lot 1 has the option to be extended for any period up to 36 months.
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)

Additional information

The invitation to tender (ITT) documents and additional information is available from CTM e-procurement portal at https://uk.eu-supply.com
Tenders or requests to participate must be submitted electronically via the CTM e-procurement portal at https://uk.eu-supply.com
If not already registered on CTM eu-supply.com you will need to register as a supplier to express interest.
II.2)

Description

II.2.1)

Title

Aseptically prepared products
Lot No:  2
II.2.2)

Additional CPV code(s)

33690000  -  Various medicinal products
33692100  -  Infusion solutions
33692500  -  Injectable solutions
33692510  -  Intravenous fluids
33693100  -  Toxins
II.2.3)

Place of performance

NUTS code:  UKK -  SOUTH WEST (ENGLAND)
Main site or place of performance:  
Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire
II.2.4)

Description of the procurement

Supply of Carboplatin, Epirubicin, Nivolumab & Paclitaxel.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 25000000.00  GBP
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 48
This contract is subject to renewal: no
II.2.10)

Information about variants

Variants will be accepted: no
II.2.11)

Information about options

Options: yes
Description of options:
The Contract for Lot 2 has the option to be extended for any period up to 36 months.
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2)

Description

II.2.1)

Title

Aseptically Prepared Products
Lot No:  3
II.2.2)

Additional CPV code(s)

33690000  -  Various medicinal products
33692100  -  Infusion solutions
33692500  -  Injectable solutions
33692510  -  Intravenous fluids
33693100  -  Toxins
II.2.3)

Place of performance

NUTS code:  UKK -  SOUTH WEST (ENGLAND)
Main site or place of performance:  
Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire
II.2.4)

Description of the procurement

Supply of Atezolizumab (Tecentriq®), Bortezomib Subcut, Docetaxel, Fluorouracil, Oxaliplatin & Vincristine.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 9000000.00  GBP
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 48
This contract is subject to renewal: no
II.2.10)

Information about variants

Variants will be accepted: no
II.2.11)

Information about options

Options: yes
Description of options:
Lot 3 has the option to be extended for any period up to 36 months.
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2)

Description

II.2.1)

Title

Aseptically Prepared Products
Lot No:  4
II.2.2)

Additional CPV code(s)

33690000  -  Various medicinal products
33692100  -  Infusion solutions
33692500  -  Injectable solutions
33692510  -  Intravenous fluids
33693100  -  Toxins
II.2.3)

Place of performance

NUTS code:  UKK -  SOUTH WEST (ENGLAND)
Main site or place of performance:  
Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire
II.2.4)

Description of the procurement

Supply of Bleomycin, Cabazitaxel, Calcium folinate, Cisplatin, Cytarabine, Daunorubicin, Ganciclovir, Suxamethonium & Vinblastine.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 1500000.00  GBP
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 48
This contract is subject to renewal: no
II.2.10)

Information about variants

Variants will be accepted: no
II.2.11)

Information about options

Options: yes
Description of options:
Lot 4 has the option to be extended for any period up to 36 months.
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section III: Legal, economic, financial and technical information

III.1)

Conditions for participation

III.1.2)

Economic and financial standing

Selection criteria as stated in the procurement documents
III.1.3)

Technical and professional ability

Selection criteria as stated in the procurement documents
III.2)

Conditions related to the contract

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : no
IV.2)

Administrative information

IV.2.2)

Time limit for receipt of tenders or requests to participate

Date:  05/06/2023
Local time:  14:00
IV.2.4)

Languages in which tenders or requests to participate may be submitted

English
IV.2.6)

Minimum time frame during which the tenderer must maintain the tender

Duration in months : 8  (from the date stated for receipt of tender)
IV.2.7)

Conditions for opening of tenders

Date:  06/06/2023
Local time:  09:00

Section VI: Complementary information

VI.1)

Information about recurrence

This is a recurrent procurement:  no
VI.3)

Additional information

The invitation to tender (ITT) documents and additional information is available from CTM e-procurement portal at: https://uk.eu-supply.com
Tenders or requests to participate must be submitted electronically via the above address.
This procurement (Lots 1, 2, 3 & 4 - RFT 73313) will be undertaken with Lot 5 framework (RFT 73320) and share the same T22/0446 Invitation to Tender documents (ITT).
The following Trusts may join any Contract(s) awarded from the Tender at any time during the Contract Period including Dorset County Hospital NHS Foundation Trust, Jersey General Hospital, Princess Elizabeth Hospital, Guernsey and University Hospitals Dorset NHS Foundation Trust.
VI.4)

Procedures for review

VI.4.1)

Review body

Peninsula Purchasing & Supply Alliance
Royal Devon & Exeter NHS Foundation Trust, Gladstone Road
Exeter
EX1 2ED
UK

VI.4.2)

Body responsible for mediation procedures

Peninsula Purchasing & Supply Alliance
Royal Devon & Exeter NHS Foundation Trust, Gladstone Road
Exeter
EX1 2ED
UK

VI.4.4)

Service from which information about the review procedure may be obtained

Peninsula Purchasing & Supply Alliance
Royal Devon & Exeter NHS Foundation Trust, Gladstone Road
Exeter
EX1 2ED
UK